P. Lebecque

发表

Reference ranges for spirometry across all ages: a new approach.

S. Stanojevic, A. Wade, J. Stocks, 2008, American journal of respiratory and critical care medicine.

Spirometry in the asthmatic child: Is FEF25–75 a more sensitive test than FEV1/FVC?

A. Coates, P. Lebecque, P. Kiakulanda, 1993, Pediatric pulmonology.

Comparison of spirometric reference values

Patrick Lebecque, Mary Corey, A. Coates, 2004, Pediatric pulmonology.

Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis.

P. Lebecque, K. Dahan, A. Mafficini, 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Inhaled phosphodiesterase type 5 inhibitors restore chloride transport in cystic fibrosis mice

P. Lebecque, E. Marbaix, P. Wallemacq, 2010, European Respiratory Journal.

Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium.

P. Lebecque, P. Nordmann, P. Tulkens, 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The Prognosis of Cystic Fibrosis - A Clinician's Perspective

P. Lebecque, 2012 .

Airway delivery of low-dose miglustat normalizes nasal potential difference in F508del cystic fibrosis mice.

P. Lebecque, R. Vanbever, P. Wallemacq, 2009, American journal of respiratory and critical care medicine.

Comparison of the RGM medium and the mycobacterial growth indicator tube automated system for isolation of non-tuberculous mycobacteria from sputum samples of cystic fibrosis patients in Belgium

P. Lebecque, E. André, A. Colmant, 2018, Journal of clinical tuberculosis and other mycobacterial diseases.

Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice.

P. Lebecque, D. Lison, E. Marbaix, 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Tracheal distensibility in cystic fibrosis.

P. Lebecque, G. Liistro, D. Stǎnescu, 1996, The European respiratory journal.

Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation.

P. Lebecque, V. Preumont, M. Buysschaert, 2007, Diabetes care.

Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis.

P. Lebecque, P. Wallemacq, T. Coste, 2008, Clinical chemistry.

Fatal meningitis due to multi-resistant Haemophilus influenzae type b

P. Lebecque, P. Piot, G. Wauters, 1985, European Journal of Pediatrics.

Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis

P. Lebecque, N. Derichs, K. De Boeck, 2009, Thorax.

The objective assessment of cough frequency: accuracy of the LR102 device

P. Lebecque, G. Liistro, S. Leconte, 2011, Cough.

REVERSAL OF CIRRHOSIS‐RELATED PULMONARY SHUNTING IN TWO CHILDREN BY ORTHOTOPIC LIVER TRANSPLANTATION

P. Lebecque, J. Laberge, J. de Ville de Goyet, 1992, Transplantation.

Agreement between multiple-breath nitrogen washout systems in children and adults.

P. Lebecque, F. Singer, W. Poncin, 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Myxomatous degeneration of the mitral valve in a child with Turner syndrome and partial anomalous pulmonary venous return

P. Lebecque, M. Stijns, J. Lintermans, 1984, European Journal of Pediatrics.

Impact of MIF Gene Promoter Polymorphism on F508del Cystic Fibrosis Patients

P. Lebecque, A. Mafficini, B. Assael, 2014, PloS one.

A randomized placebo-controlled trial of miglustat in cystic fibrosis based on nasal potential difference.

P. Lebecque, J. Dingemanse, T. Leal, 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Comparative Variability of Nasal Potential Difference Measurements in Human and Mice

P. Lebecque, P. Wallemacq, T. Leal, 2012 .

Early referral to cystic fibrosis specialist centre impacts on respiratory outcome.

P. Lebecque, F. De Baets, K. Desager, 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

A specific database for providing local and national level of integration of clinical data in cystic fibrosis.

P. Lebecque, J. Gigi, P. Mailleux, 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis.

P. Lebecque, X. Bossuyt, G. Reychler, 2006, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients

P. Lebecque, P. Vandamme, K. De Boeck, 2004, European Respiratory Journal.

In vitro evaluation of efficacy of 5 methods of disinfection on mouthpieces and facemasks contaminated by strains of cystic fibrosis patients.

P. Lebecque, J. Gigi, G. Reychler, 2005, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

ABPA in adulthood: a CFTR-related disorder

P. Lebecque, E. Marchand, X. Pepermans, 2010, Thorax.

Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic Fibrosis

P. Lebecque, D. Lison, E. Marbaix, 2013, PloS one.

Transient elastography in patients with cystic fibrosis

P. Lebecque, A. Nicolae, P. Clapuyt, 2010, Pediatric Radiology.

Outer diameter of the vermiform appendix: not a valid sonographic criterion for acute appendicitis in patients with cystic fibrosis.

P. Lebecque, C. Saint-Martin, P. Clapuyt, 2005, AJR. American journal of roentgenology.

Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum.

P. Lebecque, F. Vermeulen, R. Vanbever, 2018, Clinical science.

Needle-free iontophoresis-driven β-adrenergic sweat rate test.

P. Lebecque, F. Vermeulen, A. Mottais, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Pulse oximetry versus measured arterial oxygen saturation: A comparison of the Nellcor N100 and the Biox III

A. Coates, P. Lebecque, A. Vliers, 1991, Pediatric pulmonology.

Cystic Fibrosis-renewed hopes through research

P. Lebecque, 2012 .

Omalizumab for exacerbations of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

P. Lebecque, C. Pilette, A. Leonard, 2009, BMJ Case Reports.

and ciliated epithelium Ion transport across CF and normal murine olfactory

Seiko F. Okada, P. Lebecque, L. Ostrowski, 2011 .

Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients

P. Lebecque, M. Vaneechoutte, M. Proesmans, 2008, European Respiratory Journal.

Biological variability of the sweat chloride in diagnostic sweat tests: A retrospective analysis.

P. Lebecque, F. Vermeulen, K. De Boeck, 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients

P. Lebecque, M. Vaneechoutte, F. De Baets, 2006, European Respiratory Journal.

Sweat potassium concentration may help to identify falsification of sweat test: a case report.

P. Lebecque, P. Wallemacq, T. Leal, 2008, Clinical biochemistry.

Molecular typing and antifungal susceptibility of Exophiala isolates from patients with cystic fibrosis.

P. Lebecque, M. Hendrickx, J. Bouchara, 2012, Journal of medical microbiology.

Exophiala (Wangiella) dermatitidis and cystic fibrosis - Prevalence and risk factors.

P. Lebecque, F. Symoens, G. Reychler, 2010, Medical mycology.

Exophiala (Wangiella) dermatitidis and cystic fi brosis – Prevalence and risk factors , prevalence , selective media ,

P. Lebecque, F. Symoens, T. Leal, 2010 .

Is neonatale screening op mucoviscidose aangewezen in België

P. Lebecque, M. Neyt, M. Proesmans, 2010 .

Does In Utero Exposure to Heavy Maternal Smoking Induce Nicotine Withdrawal Symptoms in Neonates?

P. Lebecque, L. Galanti, A. Robert, 2004, Pediatric Research.

Basic protocol for transepithelial nasal potential difference measurements.

Michael R Knowles, Jean Lebacq, Patrick Lebecque, 2004, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

The wandering spleen

P. Lebecque, C. Vermylen, D. Claus, 1983, European Journal of Pediatrics.

An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis.

P. Lebecque, M. Armand, P. Wallemacq, 2007, Clinical biochemistry.

Pulmonary plasma cell granuloma

P. Lebecque, S. Spier, P. Brochu, 1987, European Journal of Pediatrics.

Mutations in the amiloride‐sensitive epithelial sodium channel in patients with cystic fibrosis‐like disease

P. Lebecque, A. Azad, M. Schwartz, 2009, Human mutation.

Single-Breath DLCO

P. Lebecque, B. Nemery, A. Frans, 1995 .

Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney.

P. Lebecque, P. Courtoy, C. Hermans, 2007, Journal of the American Society of Nephrology : JASN.

Mutations of the cystic fibrosis gene and intermediate sweat chloride levels in children.

P. Lebecque, J. Cassiman, H. Cuppens, 2002, American journal of respiratory and critical care medicine.

Measurement of respiratory system resistance by forced oscillation in normal children: A comparison with spirometric values

A. Coates, P. Lebecque, K. Desmond, 1991, Pediatric pulmonology.

Increased tissue arachidonic acid and reduced linoleic acid in a mouse model of cystic fibrosis are reversed by supplemental glycerophospholipids enriched in docosahexaenoic acid.

P. Lebecque, M. Armand, P. Wallemacq, 2009, The Journal of nutrition.

Variability of gait speed during six minutes walking test in COPD and cystic fibrosis patients.

P. Lebecque, G. Liistro, T. Pieters, 2016, Gait & posture.

Diffusion capacity and oxygen desaturation effects on exercise in patients with cystic fibrosis.

A. Coates, P. Lebecque, A. Lamarre, 1987, Chest.

Histamine challenge test in children using forced oscillation to measure total respiratory resistance.

A. Coates, P. Lebecque, S. Spier, 1987, Chest.

Impact of hypochlorite-based disinfection on bacterial contamination of cystic fibrosis patients' home-nebulisers.

P. Lebecque, J. Gigi, G. Reychler, 2009, The Journal of hospital infection.

Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice

P. Lebecque, D. Lison, E. Marbaix, 2006, Respiratory research.

Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis.

P. Lebecque, D. Lison, B. Scholte, 2009, American journal of respiratory cell and molecular biology.

Comparison of culture and qPCR for the detection of Pseudomonas aeruginosa in not chronically infected cystic fibrosis patients

P. Lebecque, M. Vaneechoutte, F. De Baets, 2010, BMC Microbiology.

Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis.

P. Lebecque, P. Wallemacq, J. Lebacq, 2008, American journal of respiratory and critical care medicine.

Respiratory resistance by the forced oscillation technique in asthmatic children and cystic fibrosis patients.

P. Lebecque, D. Stǎnescu, P Lebecque, 1997, The European respiratory journal.

41 Corrector effect of resveratrol on refractory adrenergic pathway in saliva secretion of cystic fibrosis mice

P. Lebecque, P. Wallemacq, T. Leal, 2012 .

63 Resveratrol improves chloride secretion in cystic fibrosis mice homozygous for the F508del mutation

P. Lebecque, P. Wallemacq, T. Leal, 2011 .

Miglustat effects on the basal nasal potential differences in cystic fibrosis.

P. Lebecque, J. Dingemanse, T. Leal, 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Airway ion transport impacts on disease presentation and severity in cystic fibrosis.

P. Lebecque, J. Dall'ava, I. Fajac, 2008, Clinical biochemistry.

[Mucoviscidosis: CFTR mutation-specific therapy: a ray of sunshine in a cloudy sky].

P. Lebecque, T. Leal, A. Leonard, 2013, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Modified Method to Measure Nasal Potential Difference

P. Lebecque, P. Wallemacq, J. Lebacq, 2003, Clinical chemistry and laboratory medicine.

Trying to find a cure for cystic fibrosis: CFTR biomarkers as outcomes

P. Lebecque, 2013, European Respiratory Journal.

Early referral to cystic fibrosis specialist centre impacts on respiratory outcome.

P. Lebecque, A. Malfroot, T. Leal, 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

DRESS syndrome in a patient with cystic fibrosis: A case report

P. Lebecque, A. Froidure, S. Gohy, 2017, Pediatric pulmonology.

Omalizumab for treatment of ABPA exacerbations in CF patients

P. Lebecque, C. Pilette, A. Leonard, 2009, Pediatric pulmonology.

Objective Study of Sensor Relevance for Automatic Cough Detection

Thierry Dutoit, Thomas Drugman, Ricardo Chessini, 2013, IEEE Journal of Biomedical and Health Informatics.

Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic Fibrosis

P. Lebecque, D. Lison, E. Marbaix, 2013, PloS one.

Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis

P. Lebecque, N. Derichs, I. Sermet, 2009, Thorax.